Literature DB >> 10880369

Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors.

A Saaristo1, T A Partanen, J Arola, L Jussila, M Hytönen, A Mäkitie, S Vento, A Kaipainen, H Malmberg, K Alitalo.   

Abstract

Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are important regulators of blood and lymphatic vessel growth and vascular permeability. Both blood and lymphatic vessels of the upper respiratory tract play important roles in pathological conditions, such as infections and tumors. Here we have studied the expression of VEGF-C and its receptor VEGFR-3 in the upper respiratory system by Northern blot analysis and immunohistochemistry of human tissues, and in situ mRNA hybridization of developing mouse embryos and beta-galactosidase staining of mouse embryos having a LacZ marker gene in the VEGFR-3 gene locus. The results demonstrate expression of VEGF-C and VEGFR-3 in the developing and adult nasal respiratory epithelium and in the nasal vascular plexus, respectively. Unlike in most other tissues, in the nasal mucosa VEGFR-3 is expressed in both blood and lymphatic vessels. Expression of VEGF-C was also detected in nasal and nasopharyngeal tumor islands, which were surrounded by VEGFR-3-positive angiogenic blood vessels. These results suggest that VEGF-C and VEGFR-3 have a role in the development of the nasal submucosal vascular plexus and in its normal function and that they are associated with angiogenesis in nasal and nasopharyngeal tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880369      PMCID: PMC1850213          DOI: 10.1016/S0002-9440(10)64510-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Proteolytic processing regulates receptor specificity and activity of VEGF-C.

Authors:  V Joukov; T Sorsa; V Kumar; M Jeltsch; L Claesson-Welsh; Y Cao; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

2.  Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.

Authors:  L Jussila; R Valtola; T A Partanen; P Salven; P Heikkilä; M T Matikainen; R Renkonen; A Kaipainen; M Detmar; E Tschachler; R Alitalo; K Alitalo
Journal:  Cancer Res       Date:  1998-04-15       Impact factor: 12.701

3.  Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.

Authors:  M Jeltsch; A Kaipainen; V Joukov; X Meng; M Lakso; H Rauvala; M Swartz; D Fukumura; R K Jain; K Alitalo
Journal:  Science       Date:  1997-05-30       Impact factor: 47.728

4.  A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.

Authors:  V Joukov; V Kumar; T Sorsa; E Arighi; H Weich; O Saksela; K Alitalo
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

5.  Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C.

Authors:  A Ristimäki; K Narko; B Enholm; V Joukov; K Alitalo
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

6.  Cardiovascular failure in mouse embryos deficient in VEGF receptor-3.

Authors:  D J Dumont; L Jussila; J Taipale; A Lymboussaki; T Mustonen; K Pajusola; M Breitman; K Alitalo
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

7.  Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.

Authors:  B Witzenbichler; T Asahara; T Murohara; M Silver; I Spyridopoulos; M Magner; N Principe; M Kearney; J S Hu; J M Isner
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.

Authors:  A Lymboussaki; T A Partanen; B Olofsson; J Thomas-Crusells; C D Fletcher; R M de Waal; A Kaipainen; K Alitalo
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

9.  Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization.

Authors:  S Mesiano; N Ferrara; R B Jaffe
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

10.  Vascular endothelial growth factor induces endothelial fenestrations in vitro.

Authors:  S Esser; K Wolburg; H Wolburg; G Breier; T Kurzchalia; W Risau
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

View more
  5 in total

1.  D2-40 staining in sinonasal-type hemangiopericytoma--further evidence of distinction from conventional hemangiopericytoma and solitary fibrous tumor.

Authors:  Torsten Hansen; Kathrin Katenkamp; Detlef Katenkamp
Journal:  Virchows Arch       Date:  2005-12-16       Impact factor: 4.064

2.  VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression.

Authors:  M L George; M G Tutton; F Janssen; A Arnaout; A M Abulafi; S A Eccles; R I Swift
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

Review 3.  Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

Authors:  Hayamitsu Adachi; Koichi Nakae; Shuichi Sakamoto; Chisato Nosaka; Sonoko Atsumi; Masabumi Shibuya; Nobuaki Higashi; Motowo Nakajima; Tatsuro Irimura; Yoshio Nishimura
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

4.  Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.

Authors:  Weiling He; Bing Tang; Dongjie Yang; Yuhuang Li; Wu Song; Tuckyun Cheang; Xinlin Chen; Yin Li; Lianzhou Chen; Wenhua Zhan; Wen Li; Yulong He
Journal:  World J Surg Oncol       Date:  2013-07-18       Impact factor: 2.754

5.  Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer.

Authors:  Foteinos-Ioannis Dimitrakopoulos; Georgia-Angeliki Koliou; Vassiliki Kotoula; Kyriaki Papadopoulou; Konstantinos Markou; Konstantinos Vlachtsis; Nikolaos Angouridakis; Ilias Karasmanis; Angelos Nikolaou; Amanda Psyrri; Anastasios Visvikis; Paris Kosmidis; George Fountzilas; Angelos Koutras
Journal:  Cancers (Basel)       Date:  2021-03-08       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.